SCYX Q2 2018 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$37M

Q2 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$64,000+0.0% YoY

Gross Profit

$64,000100.0% margin

Operating Income

-$8M-11965.6% margin

Net Income

-$11M-16807.8% margin

EPS (Diluted)

$-2.30

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$468,000

Balance Sheet

Total Assets

$58M

Total Liabilities

$31M

Stockholders' Equity

$27M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64,000	$64,000	+0.0%
Gross Profit	$64,000	$64,000	+0.0%
Operating Income	-$8M	-$7M	-13.5%
Net Income	-$11M	-$4M	-156.2%

Revenue Segments

License And Service

$100,000100%